home / stock / nrxp / nrxp quote
Last: | $2.58 |
---|---|
Change Percent: | 0.0% |
Open: | $2.61 |
Close: | $2.58 |
High: | $2.69 |
Low: | $2.58 |
Volume: | 20,705 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.58 | $2.61 | $2.58 | $2.69 | $2.58 | 20,705 | 07-04-2024 |
$2.58 | $2.61 | $2.58 | $2.69 | $2.58 | 20,696 | 07-03-2024 |
$2.6 | $2.57 | $2.6 | $2.69 | $2.5309 | 34,993 | 07-02-2024 |
$2.58 | $2.44 | $2.58 | $2.7 | $2.44 | 67,180 | 07-01-2024 |
$2.44 | $2.58 | $2.44 | $2.6899 | $2.4 | 110,129 | 06-28-2024 |
$2.62 | $2.5 | $2.62 | $2.766 | $2.42 | 68,711 | 06-27-2024 |
$2.41 | $2.52 | $2.41 | $2.6 | $2.35 | 132,695 | 06-26-2024 |
$2.69 | $2.6 | $2.69 | $2.7369 | $2.59 | 28,119 | 06-25-2024 |
$2.67 | $2.68 | $2.67 | $2.81 | $2.57 | 104,641 | 06-24-2024 |
$2.65 | $2.9 | $2.65 | $2.96 | $2.64 | 119,240 | 06-21-2024 |
$2.9 | $3.05 | $2.9 | $3.1 | $2.78 | 86,547 | 06-20-2024 |
$3.05 | $3.07 | $3.05 | $3.1699 | $3.02 | 41,354 | 06-19-2024 |
$3.05 | $3.07 | $3.05 | $3.1699 | $3.02 | 41,354 | 06-18-2024 |
$3.07 | $3.04 | $3.07 | $3.19 | $3.04 | 52,639 | 06-17-2024 |
$3.03 | $3.46 | $3.03 | $3.46 | $3 | 182,903 | 06-14-2024 |
$3.44 | $3.36 | $3.44 | $3.52 | $3.29 | 31,878 | 06-13-2024 |
$3.38 | $3.37 | $3.38 | $3.43 | $3.325 | 40,663 | 06-12-2024 |
$3.32 | $3.27 | $3.32 | $3.3994 | $3.2101 | 63,210 | 06-11-2024 |
$3.18 | $3.2 | $3.18 | $3.385 | $3.04 | 87,643 | 06-10-2024 |
$3.21 | $3.35 | $3.21 | $3.4 | $3.2 | 95,467 | 06-07-2024 |
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Company Name:
NRXP Stock Symbol:
NASDAQ Market:
NRX Pharmaceuticals Inc. Website:
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing PR Newswire New Drug Application (NDA) for Accelerated Approval planned for NRX-101 in people with bipolar depression and akathisia in 202...
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024 PR Newswire RADNOR, Pa. , June 20, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"...
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors PR Newswire Dr. Dennis McBride brings extensive experience in Neuroscience and its interface with Information and Medical Technology ...